Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1
pubmed:dateCreated
2005-12-26
pubmed:abstractText
Paecilomyces lilacinus is a fungal pathogen which is generally resistant to amphotericin B and certain other antifungals and is an uncommon cause of devastating fungal keratitis. In the present studies, we evaluated topical voriconazole as therapy for P. lilacinus keratitis in rabbits. Thirty eyes of 15 rabbits were studied. In five animals, the uninfected left eye was treated twice daily with voriconazole (drug control, uninfected eye). In these same animals, the right eye was infected with P. lilacinus but not treated with voriconazole (infection control eye). By day 5, the infection controls had lesions of >2.4 mm in diameter, with conjunctivitis and severe hypopyon, and were sacrificed. In the other 10 rabbits (voriconazole treatment), the right eyes were infected with P. lilacinus and treated with voriconazole beginning on day 3 after infection. Voriconazole therapy caused lesions to decrease during 8 days of therapy, after which rabbits were sacrificed (11 days postinfection). Hyphal masses were present in the control infected eyes and absent in treated infected eyes. Voriconazole was detected in all tissues of treated eyes. Topical voriconazole is effective treatment for P. lilacinus experimental keratitis, and it penetrates more deeply than the corneal tissue.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/16377696-1103806, http://linkedlifedata.com/resource/pubmed/commentcorrection/16377696-11807679, http://linkedlifedata.com/resource/pubmed/commentcorrection/16377696-12167683, http://linkedlifedata.com/resource/pubmed/commentcorrection/16377696-12594645, http://linkedlifedata.com/resource/pubmed/commentcorrection/16377696-12715306, http://linkedlifedata.com/resource/pubmed/commentcorrection/16377696-14971576, http://linkedlifedata.com/resource/pubmed/commentcorrection/16377696-15793112, http://linkedlifedata.com/resource/pubmed/commentcorrection/16377696-15909252, http://linkedlifedata.com/resource/pubmed/commentcorrection/16377696-299984, http://linkedlifedata.com/resource/pubmed/commentcorrection/16377696-311456, http://linkedlifedata.com/resource/pubmed/commentcorrection/16377696-3901331, http://linkedlifedata.com/resource/pubmed/commentcorrection/16377696-4735015, http://linkedlifedata.com/resource/pubmed/commentcorrection/16377696-575678, http://linkedlifedata.com/resource/pubmed/commentcorrection/16377696-9800664
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jan
pubmed:issn
0066-4804
pubmed:author
pubmed:issnType
Print
pubmed:volume
50
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
262-8
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed:year
2006
pubmed:articleTitle
Topical voriconazole as a novel treatment for fungal keratitis.
pubmed:affiliation
The University of Texas Health Science Center at San Antonio, Texas 78229-3900, USA.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't